Trial NCT03298412

View at ClinicalTrials.gov 
Org. Study IDs: 20150291
Secondary IDs: 2016-003255-30

Last trial update was posted on 2020-09-11

MeSH Interventions

Blinatumomab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual

Other Conditions

High-risk Diffuse Large B-cell Lymphoma

Stopping Reasons

Early Closure due to rare patient population

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID